Navigation Links
Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital

BOZEN, Sud-Tirol, Italy, July 20, 2010 /PRNewswire/ -- Health Robotics today announced that it recently signed agreements to grant exclusive CytoCare distribution rights in Spain and Portugal to world-leading IV Therapy company Grifols S.A., and to install the first-ever Cancer Therapy Robot in Spain at Vall d'Hebron University Hospital in Barcelona in November 2010.

"We are very excited to have been selected by Health Robotics as their long-term exclusive CytoCare partner in Spain and Portugal, adding the Cancer Therapy Robot in our core Iberian peninsula market to our prior i.v.STATION distribution rights. CytoCare, the world's first and only robotic system designed for the safe and sterile preparation of patient-specific hazardous IV Admixtures, represents an ideal complement to our other market-leading Pharmacy Automation products. Vall d'Hebron University Hospital has demonstrated a long trajectory of innovation, utilizing new technologies to achieve excellent peer-reviewed and published efficiency and medication safety results, with prestigious awards such as Best European Pharmacy Management, ESADE's Management Innovation, and finally the Best Health Care Ideas in 2009", stated Xavier Guix, Vice President of Marketing for Grifols' Hospital System Division".

"It is very exciting to expand our i.v.STATION relationship at such a prestigious hospital as Vall d'Hebron University Hospital, with its world-renowned cancer research program and the well-documented scientific publications by Dr. Josep Monterde and his team of scientists and pharmacists; we feel rewarded with this new contract after 1.000 Bed Bolzano General Hospital hosted an inspection team from Vall d'Hebron University Hospital in order to ascertain CytoCare's speed, flexibility, and safety in comparison with other IV Robotics companies, and demonstrating that CytoCare handled 70% of Chemo IV doses within a 4 hour time-window. Additionally, Grifols is the perfect fit for CytoCare in Spain and Portugal due to its well-established distribution channels, commitment to patient safety, its company stability and superior market footprint, and finally its world-class service infrastructure. In addition to the obvious success in expanding our partnership with Grifols and receiving a repeat endorsement from an existing Health Robotics' partner, I'm very pleased that this new contract symbolizes the first CytoCare installation in Spain, and the eight European Union member country to embrace CytoCare for its Oncology Therapy Compounding needs", stated Werner Rainer, Health Robotics' CEO.

About Vall d'Hebron University Hospital:

Vall d'Hebron University Hospital, the leading hospital complex in Catalonia and one of the largest in Spain, is comprised of four large centers - the General Area, the Maternity and Children's Area, the Traumatology and Rehabilitation Area and the Outpatient Surgery Unit (Pere Virgili Health Care Park) - which cover almost all the medical and surgical specialties. The Vall d'Hebron University Hospital, with a total of more than 1400 beds, also house various teaching centers, public health care enterprises, research centers, laboratories and other complementary facilities.

About Grifols S.A.:

Grifols International is a Spain-based company engaged in the healthcare sector and is listed on Ibex-35 stock market. Grifols is involved in the research, development, manufacturing and marketing of plasma derivates, IV therapy solutions, enteral and parenteral nutrition, diagnostic systems, pharmacy automation, and medical materials and devices. Founded in 1940, Grifols currently operates in 90 countries with more than 6.000 employees, 26 subsidiaries with combined gross revenues over EUR800 million, and a EUR3 billion market capitalization. For more information, please visit

About Health Robotics:

Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other therapy oversights and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff.

For more company information including a corporate video, please visit For additional information, please contact:

    Health Robotics S.r.l.
    Claudia Flaim, Marketing Coordinator
    Phone: +39-0471-200-372

SOURCE Health Robotics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
2. Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community
3. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
4. MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians
5. Hill-Rom Recognized by Premier Healthcare Alliance for Customer Service and Exceptional Performance
6. China Sky One Medicals Chief Financial Officers Health Issues to Restrict His Availability to Investors
7. FDA Consumer Health Information - Stolen Inhalers Pose Risk
8. Siemens Primed to Help Customers Achieve Newly-Defined Criteria for Meaningful Use of an Electronic Health Record
9. RoundTable Healthcare Partners Closes Two Funds
10. Cardinal Health Completes Acquisition of Healthcare Solutions Holding
11. Bell Medical and ITelagen Welcome Final Rule for Meaningful Use of Electronic Health Records
Post Your Comments:
(Date:11/24/2015)... 24, 2015  Figure 1, a free mobile-first network ... cases, has launched a new completely redesigned web version ... allows radiologists, who work primarily on a desktop, to ... with its radiologist user base, Figure 1 is hosting ... North America (RSNA) Annual Meeting. ...
(Date:11/24/2015)... NEW YORK , Nov. 24, 2015 iRhythm ... on advancing cardiac care, today announced that it will participate in ... Palace Hotel in New York, NY . ... to present on Tuesday December 1, 2015 at 8:50am ET. ... Inc. . --> . ...
(Date:11/24/2015)... , Nov. 24, 2015 Teledyne DALSA ... X-Ray image sensing technology, will introduce its CMOS X-Ray ... Exhibition , November 29 to December 3, at McCormick Place ... dynamic detectors for diagnostic and interventional imaging will be on ... Xineos family of advanced CMOS X-Ray detectors is the ...
Breaking Medicine Technology:
(Date:11/24/2015)... SAN FRANCISCO, CA (PRWEB) , ... November 24, ... ... launched half-cup sizes, has launched their Black Friday sale a week early, offering ... ThirdLove continues to transform the intimate apparel industry through both mobile fit technology ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... are national leaders when it comes to several aspects of orthopedic care. They ... joint replacements, orthopedic surgeries and general orthopedic care. , Becker's Hospital Review ...
(Date:11/24/2015)... California (PRWEB) , ... November 24, 2015 , ... ... Energy's LENR HHT Bolier Reactor System. Brillouin is the developer of renewable energy ... controlled low energy nuclear reactions (“LENR”), announced today that its WET™ and HHT™ ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... United States to support their local poison centers through donations on Tuesday, Dec. ... calls it “a day that inspires people to collaborate in improving their ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Aided by seed ... announced an innovative study designed to yield insights into how to detect and treat ... biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic material that is ...
Breaking Medicine News(10 mins):